Once the concept of PCR popped into Kary Mullis’ head in 1983 it wasn’t long before scientists realized they had a revolutionary technology in their hands. Because now they could take the smallest ...

With laboratory methods and diagnostics advancing apace, Francesca Lake considers whether PCR is likely to retain its crown as an essential lab method, or whether it could be replaced and consigned to ...

In its formative years PCR and its intellectual possessors had to go through some legal wrangling over the originality of the technique. In point of fact, a 13-year earlier paper by Nobelist Gobind ...

PCR—the workhorse of modern molecular biology—is charging forward using both conventional and digital methods to explore single cells and even single molecules. Nathan Blow reports. In late 1978, Ry ...

Real-time PCR or quantitative PCR (Polymerase Chain Reaction) is an advancement of the standard PCR technique, which enables continuous monitoring of the reaction and collection of data in real time.

The series of thermoelectric coolers (TECs) is engineered specifically for demanding PCR (Polymerase Chain Reaction) testing applications, delivering high reliability, precise temperature control, and ...

In Part 3 of our COVID-19 diagnostics and detection miniseries, supported by Roche, we explore the contribution PCR has made towards diagnosis during the pandemic. Providing me with an insight into ...

(MENAFN- GlobeNewsWire - Nasdaq) Major market opportunities in blood group typing include advancements in PCR and NGS technologies, growing demand for personalized medicine, and increased healthcare ...

Different PCR-based DNA fingerprinting techniques were evaluated for identification and discrimination of bacterial strains. Fifteen strains of Salmonella enterica subspecies enterica serotypes Typhi ...

Polymerase chain reaction (PCR) test kits for COVID-19 use what’s known as gene cloning – not reproductive cloning – to detect the presence or absence of the SARS-CoV-2 virus, but social media posts ...

Coexpression of EGFR, pEGFR, VEGF, pVEGF, PTEN, pAKT, and p21 in colorectal cancer patients can have IHC variability between metastases and primary tumours and for EGFR-targeted therapies, p21 and ...